Skip to main content

Table 1 Baseline characteristics of patients with KD and controls

From: Increase expression of CD177 in Kawasaki disease

Characteristic

Healthy controls n = 24

Febrile controls n = 24

KD (complete/incomplete) n = 46 (36/10)

P-value

Male gender

14

15

35 (26/9)

0.324

Age (y)

7.5 ± 1.0a

2.6 ± 0.3b

1.6 ± 0.2b (1.6 ± 0.2/1.7 ± 0.9)

< 0.001

Age range (y)

0–16

0–5

0–9 (0–5/0–9)

 

Fever duration (day)

 

5.1 ± 0.6

6.7 ± 3.4 (6.0 ± 0.4/9.1 ± 1.7)

0.06

WBC (1000/uL)

8.0 ± 0.6a

9.3 ± 1.0a

13.7 ± 0.7b (13.6 ± 0.8/14.4 ± 1.3)

< 0.001

RBC (million/Ul)

4.9 ± 0.1a

4.7 ± 0.1a

4.3 ± 0.1b (4.3 ± 0.1/4.3 ± 0.1)

< 0.001

Hemoglobin (g/dL)

12.7 ± 0.2a

12.2 ± 0.2a

11.0 ± 0.1b (11.1 ± 0.2/10.5 ± 0.2)

< 0.001

CRP (mg/L)

 

23.5 ± 4.5a

99.2 ± 11.1b (104.4 ± 12.9/ 80.5 ± 21.5)

< 0.001

CAL formation

  

22 (15/7)

 

IVIG resistance

  

8 (8/ 0)

 
  1. CAL coronary artery lesion, IVIG intravenous immunoglobulin, KD Kawasaki disease. Data expressed as mean ± SEM
  2. a vs b indicates siginifcant difference
  3. b vs b indicates no significant difference
  4. a,b Significantly important